These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32054297)

  • 1. Lower diabetes rate in patients with familial hypercholesterolaemia: What is the link?
    Parhofer KG
    Eur J Prev Cardiol; 2020 Oct; 27(15):1647-1648. PubMed ID: 32054297
    [No Abstract]   [Full Text] [Related]  

  • 2. Type 2 diabetes mellitus in heterozygous familial hypercholesterolaemia: the hazardous intersection of cardiometabolic and genetic risk.
    German CA; Shapiro MD
    Eur J Prev Cardiol; 2022 Jan; 28(16):1817-1818. PubMed ID: 33961017
    [No Abstract]   [Full Text] [Related]  

  • 3. Familial hypercholesterolaemia: New directions on the diagnosis and treatment of an old disease.
    Rallidis LS; Kosmas N
    Hellenic J Cardiol; 2020; 61(6):404-406. PubMed ID: 32681886
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular senescence, telomeres, and cardiovascular risk in familial hypercholesterolaemia.
    Banach M; Penson PE
    Eur J Prev Cardiol; 2022 May; 29(5):718-720. PubMed ID: 33624078
    [No Abstract]   [Full Text] [Related]  

  • 5. Absence of Coronary Artery Calcification in Middle-Aged Familial Hypercholesterolemia Patients Without Atherosclerotic Cardiovascular Disease.
    Mszar R; Grandhi GR; Valero-Elizondo J; Virani SS; Blankstein R; Blaha M; Mata P; Miname MH; Al Rasadi K; Krumholz HM; Santos RD; Nasir K
    JACC Cardiovasc Imaging; 2020 Apr; 13(4):1090-1092. PubMed ID: 31843585
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study.
    Mundal L; Veierød MB; Halvorsen T; Holven KB; Ose L; Iversen PO; Tell GS; Leren TP; Retterstøl K
    Eur J Prev Cardiol; 2016 Dec; 23(18):1962-1969. PubMed ID: 27558979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).
    Descamps OS; Van Caenegem O; Hermans MP; Balligand JL; Beauloye C; Bondue A; Carlier S; Castermans E; Chenot F; Claeys M; De Block C; de Leener A; De Meester A; Demeure F; De Raedt H; Desmet W; Elegeert I; Guillaume M; Hoffer E; Kacenelenbogen R; Lancellotti P; Langlois M; Leone A; Mertens A; Paquot N; Vanakker O; Vanoverschelde JL; Verhaegen A; Vermeersch P; Wallemacq C; Rietzschel E;
    Atherosclerosis; 2018 Oct; 277():369-376. PubMed ID: 30270073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First insights from the EAS familial hypercholesterolaemia collaboration registry: FH is still underdiagnosed and undertreated.
    Stock J
    Atherosclerosis; 2019 Nov; 290():138-139. PubMed ID: 31610884
    [No Abstract]   [Full Text] [Related]  

  • 10. Global Familial Hypercholesterolaemia Studies Collaboration (FHSC).
    Stock JK
    Atherosclerosis; 2021 Nov; 337():57-58. PubMed ID: 34686380
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence and treatment of familial hypercholesterolaemia in Australian communities.
    Watts GF; Shaw JE; Pang J; Magliano DJ; Jennings GL; Carrington MJ
    Int J Cardiol; 2015 Apr; 185():69-71. PubMed ID: 25791093
    [No Abstract]   [Full Text] [Related]  

  • 12. Familial hypercholesterolaemia: too many lost opportunities.
    Cuchel M; McGowan MP
    Lancet; 2021 Nov; 398(10312):1667-1668. PubMed ID: 34506745
    [No Abstract]   [Full Text] [Related]  

  • 13. Very high-risk familial hypercholesterolaemia patients in real life: The remaining gap in achieving the current LDL-C targets despite the use of PCSK9 inhibitors.
    Rallidis LS; Liberopoulos EN; Vlachopoulos C; Skoumas I; Kolovou G; Anastasiou G; Dima I; Tousoulis D; Iliodromitis E
    Atherosclerosis; 2020 Sep; 309():67-69. PubMed ID: 32859385
    [No Abstract]   [Full Text] [Related]  

  • 14. [Management of familial heterozygous hypercholesterolaemia. Position paper of the Polish Lipid Expert Forum].
    Rynkiewicz A; Cybulska B; Banach M; Filipiak KJ; Guzik T; Idzior Waluś B; Imiela J; Jankowski P; Kłosiewicz Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T;
    Kardiol Pol; 2013; 71(1):107-11. PubMed ID: 23348551
    [No Abstract]   [Full Text] [Related]  

  • 15. DNA sequencing in familial hypercholesterolaemia: the next generation.
    Lazarte J; Hegele RA
    Eur J Prev Cardiol; 2021 Jul; 28(8):873-874. PubMed ID: 33623969
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of DNA-confirmed familial hypercholesterolaemia in young patients with myocardial infarction.
    Wald DS; Bangash FA; Bestwick JP
    Eur J Intern Med; 2015 Mar; 26(2):127-30. PubMed ID: 25682442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of early recognition of heterozygous familial hypercholesterolaemia.
    Ryan A; Byrne CD
    Curr Opin Lipidol; 2015 Aug; 26(4):298-303. PubMed ID: 26103611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hypercholesterolemia in primary care in Germany. Diabetes and cardiovascular risk evaluation: Targets and Essential Data for Commitment of Treatment (DETECT) study.
    Schmidt N; Schmidt B; Dressel A; Gergei I; Klotsche J; Pieper L; Scharnagl H; Kleber ME; März W; Lehnert H; Pittrow D; Stalla G; Wittchen HU; Grammer TB
    Atherosclerosis; 2017 Nov; 266():24-30. PubMed ID: 28946037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology.
    De Backer G; Besseling J; Chapman J; Hovingh GK; Kastelein JJ; Kotseva K; Ray K; Reiner Ž; Wood D; De Bacquer D;
    Atherosclerosis; 2015 Jul; 241(1):169-75. PubMed ID: 25997074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.
    Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS
    J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.